Skip to main content
OpenTrials

Clinical trial condition

Porphyrias, Hepatic

Explore clinical trials studying Porphyrias, Hepatic. Study availability and eligibility vary by location and protocol.

47 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Porphyrias, Hepatic trial results

Recruiting

Observational Study of Adults and Adolescents With Erythropoietic Protoporphyria (EPP) and X-linked Porphyria (XLP)

NCT07567131

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Erythropoietic Protoporphyria (EPP), +11 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Mount Sinai School of Medicine New York, United States
  • Wake Forest University Baptist Health - Dept of Gastroenterology Wake Forest, North Carolina, United States
  • Temple University Philadelphia, Pennsylvania, United States
View all 19 locations
View Trial Details
Recruiting

ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP)

NCT04883905

Conditions
Acute Hepatic Porphyria, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Coproporphyria, Hereditary, +10 more
Locations
  • Clinical Trial Site Birmingham, Alabama, United States
  • Clinical Trial Site Gilbert, Arizona, United States
  • Clinical Trial Site San Francisco, California, United States
  • Clinical Trial Site Baltimore, Maryland, United States
View all 30 locations
View Trial Details
Recruiting

Clinical Research on Acute Intermittent Porphyria and the Use of Carbohydrate-Rich Diet as a Treatment

NCT06273644

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Genetic Diseases, Inborn, +9 more
Locations
  • Nordland Hospital Trust Bodø, Nordland, Norway
  • Studieenheten, Akademiskt Specialistcentrum, Stockholm läns sjukvårdsområde, Region Stockholm Stockholm, Sweden
  • Norrland University Hospital Umeå, Sweden
View Trial Details
Enrolling by Invitation

HELIOS: Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP or XLP

NCT05883748

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Erythropoietic Protoporphyria, +10 more
Locations
  • University of Alabama Hospital Birmingham, Alabama, United States
  • University of California San Francisco San Francisco, California, United States
  • University of Miami Miller School of Medicine Miami, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View all 21 locations
View Trial Details
Completed

Effect of Oral Cimetidine in the Protoporphyrias

NCT05020184

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Erythropoietic Protoporphyria, +13 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Atrium Health Wake Forest Baptist Medical Center Winston-Salem, North Carolina, United States
  • University of Texas Medical Branch Galveston, Texas, United States
View Trial Details
Completed

INcreased Sun Exposure Without Pain In Research Participants With EPP or XLP

NCT06144840

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Erythropoietic Protoporphyria (EPP), +12 more
Locations
  • Marvel Clinical Research, LLC Huntington Beach, California, United States
  • University of California at San Francisco San Francisco, California, United States
  • University Of Miami School Of Medicine, Center For Liver Diseases Miami, Florida, United States
  • MGH Boston, Massachusetts, United States
View all 35 locations
View Trial Details

Related conditions